Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.

No abstract is available for this paper.

• Publication year

  1971

• Venue

  Applied microbiology

• Publication date

  1971-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AEM.21.5.837-840.1971PMID 4930037PMCID PMC377292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of Enterobacteriaceae in the Clinical Microbiology Laboratory

  1970cited by this paper
• Serratia marcescens: Biochemical, Serological, and Epidemiological Characteristics and Antibiotic Susceptibility of Strains Isolated at Boston City Hospital

  1970cited by this paper
• Epidemiological Fingerprinting of Pseudomonas aeruginosa by the Production of and Sensitivity to Pyocin and Bacteriophage

  1969cited by this paper
• Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage.

  1969cited by this paper
• An outbreak of Serratia marcescens, and its control.

  1969cited by this paper
• Properties and Characteristics of a Bacteriocin from Serratia marcescens

  1969cited by this paper
• Colicins and related bacteriocins.

  1967cited by this paper
• Bacteriocins and phages produced by Serratia marcescens.

  1966influential reference
• [Study of the bacteriocinogenic property in the genus Serratia].

  1961cited by this paper
• A Method for Typing Shigella sonnei, using Colicine Production as a Marker

  1958cited by this paper

• Perspectives in the Research on Antimicrobial Peptides

  2014cites this paper
• Antimicrobial Compounds

  2014cites this paper
• Friend or foe? A review of the mechanisms that drive Serratia towards diverse lifestyles.

  2013cites this paper
• Proteinase zymograms ofSerratia marcescens as an epidemiological tool

  2007cites this paper
• Epidemiological survey of an outbreak of multiresistantSerratia marcescens by PCR-fingerprinting

  2005cites this paper
• Phage Associated Bacteriocins Reveal a Novel Mechanism for Bacteriocin Diversification in Klebsiella

  2005cites this paper
• Antibiotic Susceptibility of Serratia marcescens and Serratia liquefaciens

  2000cites this paper
• Typing of nosocomial strains of Serratia marcescens: comparison of pulsed-field gel electrophoresis of macrorestriction fragments with biotyping, esterase typing and ribotyping.

  1998cites this paper
• Surveillance of Pseudomonas aeruginosa in Intensive Care Units: Clusters of Nosocomial Cross-Infection and Encounter of a Multiple-Antibiotic Resistant Strain

  1998cites this paper
• Typing of nosocomial strains of Serratia marcescens: comparison of restriction enzyme cleaved genomic DNA fragment (PFGE) analysis with bacteriocin typing, biochemical profiles and serotyping.

  1996cites this paper
• Phenotypic variation of clinical Serratia marcescens isolates repeatedly recovered from individual patients.

  1996cites this paper
• Ribotyping for use in studying molecular epidemiology of Serratia marcescens: comparison with biotyping

  1995cites this paper
• Typage de 38 souches pigmentes de Serratia marcescens impliques dans des infections nosocomiales

  1995cites this paper
• Combination of biotyping and electrophoretic patterns of esterases for differentiation of nosocomial Serratia marcescens strains.

  1995cites this paper
• Epidemiological survey of an outbreak of multiresistantSerratia marcescens by PCR-fingerprinting

  1995cites this paper
• Taurolidine: in vitro activity against multiple-antibiotic-resistant, nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae.

  1993cites this paper
• Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens

  1993cites this paper
• Comparaison de deux techniques de marcescinotypie réalisées sur 290 souches de Serratia marcescens à caractère épidémique

  1993cites this paper
• Serotyping of Serratia marcescens: detection of two new O-antigens (O25 and O26).

  1991cites this paper
• Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.

  1991cites this paper
• Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.

  1991cites this paper
• [Nosocomial septicemia and pseudobacteremia caused by Serratia marcescens].

  1988cites this paper
• Drug resistance and R plasmid in clinical isolates of Serratia marcescens at Shinshu University Hospital.

  1988cites this paper
• Interet de la marcescinotypie dans les infections nosocomiales a Serratia marcescens

  1987cites this paper
• Epidemiological and bacteriological investigation of Serratia marcescens epidemic in a nursery and in a neonatal intensive care unit

  1984cites this paper
• Nosocomial Infection with Serratia marcescens: Comparison of Bacteriocin Types and Antibiograms between Two University Hospitals

  1984cites this paper
• 臨床分離 Enterobacter cloacae のBacteriocin Typingと考察

  1984cites this paper
• [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].

  1983cites this paper
• Comparison of two methods for bacteriocin typing of Serratia marcescens

  1983cites this paper
• State of the art: typing of Serratia marcescens.

  1982cites this paper
• Basic Concepts in Microbial Aerosols

  1982cites this paper
• Bacteriocin Typing ofClinical Isolates ofEnterobacter cloacae

  1982cites this paper
• Transfer of drug-resistance plasmids by conjugation from nosocomial strains of Serratia marcescens to Escherichia coli in biological fluids of human origin.

  1982cites this paper
• Bacteriocin typing of clinical isolates of Enterobacter cloacae

  1982cites this paper
• An investigation of hospital infections by strains of Serratia.

  1982cites this paper
• An Epidemiological Study of Serratia marcescens Infections by Bacteriocin Typing

  1982cites this paper
• Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.

  1981cites this paper
• Bacteriocintypisierung von Enterobacter cloacae-Stämmen

  1981cites this paper
• [Bacteriocin typing of Enterobacter cloacae strains (author's transl)].

  1981cites this paper
• Gentamicin-resistant Serratia marcescens endophthalmitis.

  1980cites this paper
• Typing of Proteus mirabilis by Bacteriocin Production and Sensitivity as a Possible Epidemiological Marker

  1980cites this paper
• [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].

  1980cites this paper
• Typing ofProteus mirabilis byBacteriocin Production and Sensitivity asaPossible Epidemiological Marker

  1980cites this paper
• Bacteriocin typing of Serratia marcescens. A simplified system.

  1979cites this paper
• The development and assessment of a bacteriocin typing method for Klebsiella

  1979cites this paper
• Nonspecific aminoglycoside cross-resistance of Serratia marcescens.

  1979cites this paper
• Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.

  1979cites this paper
• Serotyping of Serratia marcescens: current status of seven recently described flagellar (H) antigens

  1979cites this paper
• Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.

  1979cites this paper
• Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.

  1979cites this paper
• In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.

  1979cites this paper
• Antibiotic susceptibility of clinical isolates of Serratia marcescens compared with sensitivity to group A (phage tail) bacteriocins.

  1978cites this paper
• Infektionen durch Chromobacterium, Serratia, Erwinia und Flavobacterium (sog. Chromobakteriosen)

  1978cites this paper
• Chapter VI Bacteriocin Typing of Clinical Isolates of Serratia marcescens

  1978cites this paper
• Biotyping of Serratia marcescens and its use in epidemiological studies

  1978cites this paper
• Phenotypic variations of bacteriocin susceptibility, O-antigen determinants, and serum susceptibility among isolates of a multiple-drug-resistant, nosocomially significant strain of Serratia marcescens.

  1978cites this paper
• Serotyping of Serratia marcescens: determination of serogroup (O) antigens and serological cross-reactions.

  1978cites this paper
• A comparison of typing methods for Serratia marcescens

  1977cites this paper
• Serotyping of Serratia marcescens: evaluation of Le Minor's H-immobilization test and description of three new flagellar H antigens

  1977cites this paper
• Serotyping ofSerratia marcescens: Evaluation ofLeMinor's H-Immobilization TestandDescription ofThreeNew Flagellar H Antigens

  1977cites this paper
• Combined Serotyping andBiotyping ofSerratia marcescens

  1976cites this paper
• Combined serotyping and biotyping of Serratia marcescens

  1976cites this paper
• RFactor-Mediated Antibiotic Resistance inSerratia marcescens

  1976cites this paper
• Bacteriocin (klebocin) sensitivity typing of klebsiella

  1976cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. VI. Calcium ion-dependent biological activity of subgroup II bacteriocins.

  1976cites this paper
• R Factor-Mediated Antibiotic Resistance in Serratia marcescens

  1976cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. V. Serological characterization of subgroup I and II bacteriocins.

  1976cites this paper
• Gram-Negative Rods as Agents of Nosocomial Disease: Some Recent Developments, with Comments on Mixed Cultures

  1975cites this paper
• Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.

  1975cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. II. Further characterization of subgroup I and II bacteriocins.

  1974cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. IV. Preliminary characterization of receptors of subgroup II bacteriocins.

  1974cites this paper
• [Serratia marcescens infections. Bacteriological study, antibiogram, and clinical significance].

  1974cites this paper
• Relation of Cell Wall Lipid Content of Serratia marcescens to Resistance to Antimicrobial Agents

  1974cites this paper
• Continued epidemiological surveillance of Serratia marcescens infections by bacteriocin typing, with particular reference to strains isolated at Erlangen.

  1974cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. III. Inhibition of beta-galactosidase activity (ONPG-hydrolysis) in sensitive indicator cells.

  1974cites this paper
• Relation ofCell WallLipid Content ofSerratia marcescens toResistance toAntimicrobial Agents

  1974cites this paper
• Studies on group A (phage tail) bacteriocins of Serratia marcescens. I. Phenotypic variation of producer and indicator strains.

  1973cites this paper
• [A study on the epidemiology of Sarratia marcescens using bacteriocin typing].

  1973cites this paper
• Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.

  1972cites this paper
• The genus Erwinia: enterobacteria pathogenic to plants and animals.

  1972cites this paper
• Bacteriophage Typing of Clinically Isolated Serratia marcescens

  1972cites this paper
• Bacteriocin typing of Serratia marcescens isolates of known serotype-group.

  1972cites this paper
• Bacteriocin Typing of Serratia marcescens Isolates of Known Serotype/-Group

  1972cites this paper
• Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.

  1972cites this paper
• Epidemiological Differentiation of Serratia marcescens: Typing by Bacteriocin Production

  1972cites this paper
• Studies on group A bacteriocins of Serratia marcescens: preliminary characterization of two subgroups of bacteriocins.

  1972cites this paper
• Epidemiological Differentiation of Serratia marcescens: Typing by Bacteriocin Sensitivity

  1972cites this paper
• Inhibition of induction of group A bacteriocins ofSerratia marcescens by rifampin

  1972cites this paper
• Bacteriophage typing of clinically isolated Serratia marcescens.

  1972cites this paper
• Epidemiological Surveillance of Serratia marcescens Infections by Bacteriocin Typing

  1971cites this paper
• Bacteriocinogeny inProteus rettgeri

  1971cites this paper
• Epidemiological Surveillance ofSerratia marcescens Infections byBacteriocin Typing

  1971cites this paper
• Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.

  1971cites this paper
• Bacteriocinogeny in Proteus rettgeri.

  1971cites this paper
• Serotyping of Serratia marcescens: Current Status of Seven Recently Described Flagellar (H) Antigens

  year unknowncites this paper
• Biotyping of Serratia marcescens and Its Use in Epidemiological Studies

  year unknowncites this paper
• Infections by Bacteriocin Typing: Investigation

  year unknowncites this paper